254 related articles for article (PubMed ID: 11756559)
1. Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence.
Rane SG; Cosenza SC; Mettus RV; Reddy EP
Mol Cell Biol; 2002 Jan; 22(2):644-56. PubMed ID: 11756559
[TBL] [Abstract][Full Text] [Related]
2. Cooperativity of Cdk4R24C and Ras in melanoma development.
Chawla R; Procknow JA; Tantravahi RV; Khurana JS; Litvin J; Reddy EP
Cell Cycle; 2010 Aug; 9(16):3305-14. PubMed ID: 20703083
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous and UV radiation-induced multiple metastatic melanomas in Cdk4R24C/R24C/TPras mice.
Hacker E; Muller HK; Irwin N; Gabrielli B; Lincoln D; Pavey S; Powell MB; Malumbres M; Barbacid M; Hayward N; Walker G
Cancer Res; 2006 Mar; 66(6):2946-52. PubMed ID: 16540642
[TBL] [Abstract][Full Text] [Related]
4. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors.
Sotillo R; Dubus P; Martín J; de la Cueva E; Ortega S; Malumbres M; Barbacid M
EMBO J; 2001 Dec; 20(23):6637-47. PubMed ID: 11726500
[TBL] [Abstract][Full Text] [Related]
5. Activating point mutations in cyclin-dependent kinase 4 are not seen in sporadic pituitary adenomas, insulinomas or Leydig cell tumours.
Vax VV; Bibi R; Diaz-Cano S; Gueorguiev M; Kola B; Borboli N; Bressac-de Paillerets B; Walker GJ; Dedov II; Grossman AB; Korbonits M
J Endocrinol; 2003 Aug; 178(2):301-10. PubMed ID: 12904177
[TBL] [Abstract][Full Text] [Related]
6. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status.
Rheinwald JG; Hahn WC; Ramsey MR; Wu JY; Guo Z; Tsao H; De Luca M; Catricalà C; O'Toole KM
Mol Cell Biol; 2002 Jul; 22(14):5157-72. PubMed ID: 12077343
[TBL] [Abstract][Full Text] [Related]
7. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
[TBL] [Abstract][Full Text] [Related]
8. Absence of R24C mutation of the CDK4 gene in leukemias and solid tumors.
Mori N; Yang R; Kawamata N; Miller CW; Mizoguchi H; Koeffler HP
Int J Hematol; 2003 Apr; 77(3):259-62. PubMed ID: 12731669
[TBL] [Abstract][Full Text] [Related]
9. Increased angiogenesis in Cdk4(R24C/R24C):Apc(+/Min) intestinal tumors.
Abedin ZR; Ma Z; Reddy EP
Cell Cycle; 2010 Jun; 9(12):2456-63. PubMed ID: 20603602
[TBL] [Abstract][Full Text] [Related]
10. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
[TBL] [Abstract][Full Text] [Related]
11. Invasive melanoma in Cdk4-targeted mice.
Sotillo R; García JF; Ortega S; Martin J; Dubus P; Barbacid M; Malumbres M
Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13312-7. PubMed ID: 11606789
[TBL] [Abstract][Full Text] [Related]
12. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA
Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the abnormal pancreatic development, reduced growth and infertility in Cdk4 mutant mice.
Mettus RV; Rane SG
Oncogene; 2003 Nov; 22(52):8413-21. PubMed ID: 14627982
[TBL] [Abstract][Full Text] [Related]
14. Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation.
Rodriguez-Puebla ML; Miliani de Marval PL; LaCava M; Moons DS; Kiyokawa H; Conti CJ
Am J Pathol; 2002 Aug; 161(2):405-11. PubMed ID: 12163365
[TBL] [Abstract][Full Text] [Related]
15. Requirement of Cdk4 for v-Ha-ras-Induced Breast Tumorigenesis and Activation of the v-ras-Induced Senescence Program by the R24C Mutation.
Reddy HK; Graña X; Dhanasekaran DN; Litvin J; Reddy EP
Genes Cancer; 2010 Jan; 1(1):69-80. PubMed ID: 20634902
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts.
Alcorta DA; Xiong Y; Phelps D; Hannon G; Beach D; Barrett JC
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13742-7. PubMed ID: 8943005
[TBL] [Abstract][Full Text] [Related]
17. Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity.
Sotillo R; Renner O; Dubus P; Ruiz-Cabello J; Martín-Caballero J; Barbacid M; Carnero A; Malumbres M
Cancer Res; 2005 May; 65(9):3846-52. PubMed ID: 15867383
[TBL] [Abstract][Full Text] [Related]
18. Sequential extension of proliferative lifespan in human fibroblasts induced by over-expression of CDK4 or 6 and loss of p53 function.
Morris M; Hepburn P; Wynford-Thomas D
Oncogene; 2002 Jun; 21(27):4277-88. PubMed ID: 12082615
[TBL] [Abstract][Full Text] [Related]
19. Distinct and nonoverlapping roles for pRB and cyclin D:cyclin-dependent kinases 4/6 activity in melanocyte survival.
Yu BD; Becker-Hapak M; Snyder EL; Vooijs M; Denicourt C; Dowdy SF
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14881-6. PubMed ID: 14630948
[TBL] [Abstract][Full Text] [Related]
20. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
